ADVANCED TUMORS
Clinical trials for ADVANCED TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug SIBP-A10 tested in advanced cancer patients – early safety check
Disease control Recruiting nowThis early-stage trial tests a new drug called SIBP-A10 in 160 adults with advanced tumors that have not responded to other treatments. The main goal is to check the drug's safety and find the best dose for future studies. Participants will be closely monitored for side effects a…
Matched conditions: ADVANCED TUMORS
Phase: PHASE1 • Sponsor: Shanghai Institute Of Biological Products • Aim: Disease control
Last updated May 17, 2026 04:23 UTC
-
New experimental drug MDX2004 enters human trials for advanced cancers
Disease control Recruiting nowThis study tests a new drug, MDX2004, in 235 adults with advanced solid tumors that have spread or cannot be removed. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. Participants must be 18 or older and have at least one measurable t…
Matched conditions: ADVANCED TUMORS
Phase: PHASE1, PHASE2 • Sponsor: ModeX Therapeutics, An OPKO Health Company • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New cancer drug AL58805 enters first human tests
Disease control Recruiting nowThis early-stage study tests a new drug called AL58805 in about 40 people with advanced solid tumors that have not responded to standard treatments. The main goal is to find the safest dose and understand how the body processes the drug. Researchers will monitor side effects and …
Matched conditions: ADVANCED TUMORS
Phase: PHASE1 • Sponsor: Advenchen Laboratories Nanjing Ltd. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for advanced cancers? early trial of CS23546 begins
Disease control Recruiting nowThis study is testing a new drug called CS23546 in people with advanced solid tumors or lymphoma that have not responded to or cannot tolerate standard treatments. The main goals are to find a safe dose and understand how the drug works in the body. About 156 participants will ta…
Matched conditions: ADVANCED TUMORS
Phase: PHASE1 • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
Promising cancer drug tarlatamab tested in new tumor types
Disease control Recruiting nowThis study tests the drug tarlatamab in people with advanced tumors that have a protein called DLL3. The goal is to see if the drug can shrink or control these tumors. About 29 adults with advanced DLL3-expressing cancers will receive tarlatamab and be monitored for response and …
Matched conditions: ADVANCED TUMORS
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 04, 2026 16:19 UTC